Structural Biology in Cancer Research
Track 15: Structural Biology in Cancer Research
The main aim of integrating Structural Biology data into cancer research is to style and find out novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Consequently, variety of Structural Biologists are conducting cancer research, to speed-up the method of understanding the mechanism of biomolecules so as to enhance the newer cancer therapies.
Major a part of research is being administered within the area of cancer. The most aim is to style and find out novel and effective drugs to cure the disease. Structural Biology combined with molecular modelling mainly aims at drug designing. Subsequently, numerous team leaders in Structural biology perform cancer research to accelerate the exploitation of molecular understanding of biomolecules within the advancement of novel cancer therapies.
Related Conference of Structural Biology in Cancer Research
Structural Biology in Cancer Research Conference Speakers
Recommended Sessions
- Gene regulation and Cell Signalling
- Structural Enzymology
- 3-D Structure Determination
- Advancements in structural Biology
- Biochemistry and Biophysics
- Computational Approach in Structural Biology
- Drug Designing and Biomarkers
- Frontiers in Structural Biology
- Hybrid approaches in Structure prediction
- Molecular Biology
- Molecular biology techniques
- Molecular Modelling and Dynamics
- Proteomics and Genomics
- Sequencing Analysis
- Structural Bioinformatics
- Structural Biology
- Structural Biology Databases
- Structural Biology in Cancer Research
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)